- 全部删除
您的购物车当前为空
Nedometinib (NFX-179) 是一种选择性丝裂原活化蛋白激酶激酶 (MEK1) 抑制剂,具有抗癌抗肿瘤活性,抑制皮肤中的 MAPK 通路信号传导,以剂量依赖性方式抑制人鳞状细胞系的生长,可用于研究恶性肿瘤。


为众多的药物研发团队赋能,
让新药发现更简单!
Nedometinib (NFX-179) 是一种选择性丝裂原活化蛋白激酶激酶 (MEK1) 抑制剂,具有抗癌抗肿瘤活性,抑制皮肤中的 MAPK 通路信号传导,以剂量依赖性方式抑制人鳞状细胞系的生长,可用于研究恶性肿瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 329 | In stock | |
| 5 mg | ¥ 787 | In stock | |
| 10 mg | ¥ 1,170 | In stock | |
| 25 mg | ¥ 1,820 | In stock | |
| 50 mg | ¥ 2,970 | In stock | |
| 100 mg | ¥ 4,460 | In stock | |
| 200 mg | ¥ 6,270 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 813 | In stock |
Nedometinib 相关产品
| 产品描述 | Nedometinib (NFX-179) is a selective mitogen-activated protein kinase kinase (MEK1) inhibitor with anticancer and antitumor activity, inhibits MAPK pathway signaling in the skin, inhibits the growth of human squamous cell lines in a dose-dependent manner, and can be used to study malignant tumors. |
| 别名 | NFX-179, NFX179, NFX 179 |
| 分子量 | 470.24 |
| 分子式 | C17H16FIN4O3 |
| CAS No. | 2252314-46-6 |
| Smiles | O=C(NOCCO)C=1C=2C=CC=NC2N(C1NC3=CC=C(I)C=C3F)C |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (170.13 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容